Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease
Yasuhiko Yoshida(Hyogo Medical University), Jiro Fujimoto(Harvard University), Yuji Iimuro(Yamanashi Prefectural Central Hospital), Tadamichi Hirano(Hyogo Medical University), Gakuhei Son(Hyogo Medical University), Takehito Imado(Hyogo Medical University), Tsuyoshi Iwasaki(Sumitomo Chemical (Japan))
American Journal of Physiology-Gastrointestinal and Liver Physiology
August 31, 2007
Cited by 9
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.
|Journal of Clinical Investigation|1998|454